Incidence of SARS-CoV-2 Infection Among People Experiencing Homelessness in Toronto, Canada.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 03 2023
Historique:
entrez: 13 3 2023
pubmed: 14 3 2023
medline: 16 3 2023
Statut: epublish

Résumé

People experiencing homelessness are at high risk of SARS-CoV-2 infection. Incident infection rates have yet to be established in these communities and are needed to inform infection prevention guidance and related interventions. To quantify the SARS-CoV-2 incident infection rate among people experiencing homelessness in Toronto, Canada, in 2021 and 2022 and to assess factors associated with incident infection. This prospective cohort study was conducted among individuals aged 16 years and older who were randomly selected between June and September 2021 from 61 homeless shelters, temporary distancing hotels, and encampments in Toronto, Canada. Self-reported housing characteristics, such as number sharing living space. Prevalence of prior SARS-CoV-2 infection in summer 2021, defined as self-reported or polymerase chain reaction (PCR)- or serology-confirmed evidence of infection at or before the baseline interview, and SARS-CoV-2 incident infection, defined as self-reported or PCR- or serology-confirmed infection among participants without history of infection at baseline. Factors associated with infection were assessed using modified Poisson regression with generalized estimating equations. The 736 participants (415 of whom did not have SARS-CoV-2 infection at baseline and were included in the primary analysis) had a mean (SD) age of 46.1 (14.6) years; 486 (66.0%) self-identified as male. Of these, 224 (30.4% [95% CI, 27.4%-34.0%]) had a history of SARS-CoV-2 infection by summer 2021. Of the remaining 415 participants with follow-up, 124 experienced infection within 6 months, representing an incident infection rate of 29.9% (95% CI, 25.7%-34.4%), or 5.8% (95% CI, 4.8%-6.8%) per person-month. Report after onset of the SARS-CoV-2 Omicron variant was associated with incident infection, with an adjusted rate ratio (aRR) of 6.28 (95% CI, 3.94-9.99). Other factors associated with incident infection included recent immigration to Canada (aRR, 2.74 [95% CI, 1.64-4.58]) and alcohol consumption over the past interval (aRR, 1.67 [95% CI, 1.12-2.48]). Self-reported housing characteristics were not significantly associated with incident infection. In this longitudinal study of people experiencing homelessness in Toronto, SARS-CoV-2 incident infection rates were high in 2021 and 2022, particularly once the Omicron variant became dominant in the region. Increased focus on homelessness prevention is needed to more effectively and equitably protect these communities.

Identifiants

pubmed: 36912833
pii: 2802351
doi: 10.1001/jamanetworkopen.2023.2774
pmc: PMC10011938
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e232774

Subventions

Organisme : CIHR
ID : FDN VR5-173211
Pays : Canada

Références

PLoS Negl Trop Dis. 2021 Oct 19;15(10):e0009754
pubmed: 34665803
BMC Public Health. 2022 Jun 27;22(1):1261
pubmed: 35761270
PLoS One. 2021 Jun 15;16(6):e0252886
pubmed: 34129635
Clin Transl Immunology. 2022 Mar 23;11(3):e1380
pubmed: 35356067
BMJ Open. 2023 Feb 23;13(2):e065734
pubmed: 36822808
Lancet Public Health. 2021 Apr;6(4):e202-e209
pubmed: 33556328
Addiction. 2022 Jul;117(7):1908-1919
pubmed: 35129232
N Engl J Med. 2022 Jun 16;386(24):2337-2339
pubmed: 35584302
CMAJ. 2020 Jun 29;192(26):E716-E719
pubmed: 32601252
JAMA. 2020 Nov 3;324(17):1781-1782
pubmed: 32940635
Ann Intern Med. 2021 Jan;174(1):42-49
pubmed: 32931328
J Migr Health. 2021;3:100041
pubmed: 33903857
N Engl J Med. 2020 Sep 24;383(13):1283-1286
pubmed: 32857487
Clin Microbiol Infect. 2021 Oct;27(10):1520.e1-1520.e5
pubmed: 34111590
PLoS One. 2021 Sep 15;16(9):e0255498
pubmed: 34525096
JAMA Netw Open. 2021 Dec 1;4(12):e2138464
pubmed: 34902035
Med Care. 1997 Mar;35(3):287-90
pubmed: 9071259
BMJ Open. 2022 Aug 17;12(8):e064225
pubmed: 35977770
BMJ Glob Health. 2022 Mar;7(3):
pubmed: 35277428
MMWR Morb Mortal Wkly Rep. 2020 May 01;69(17):521-522
pubmed: 32352957
Nat Med. 2022 Nov;28(11):2398-2405
pubmed: 36357676
JAMA. 2020 Jun 2;323(21):2191-2192
pubmed: 32338732
West J Emerg Med. 2020 Aug 17;21(5):1048-1053
pubmed: 32970553
BMJ Open. 2021 Nov 23;11(11):e053201
pubmed: 34815286
Nutrients. 2021 Sep 23;13(10):
pubmed: 34684318
Am J Epidemiol. 1978 Jan;107(1):71-6
pubmed: 623091
Clin Infect Dis. 2022 Aug 24;75(1):e157-e164
pubmed: 35040947
Clin Infect Dis. 2022 Aug 24;75(1):e208-e215
pubmed: 34755830
Ann Thorac Surg. 2016 May;101(5):1644-5
pubmed: 27106412
Int J Epidemiol. 2018 Feb 1;47(1):236-245
pubmed: 29024978
Lancet. 2014 Oct 25;384(9953):1529-40
pubmed: 25390578
Can J Public Health. 2022 Feb;113(1):117-125
pubmed: 34919211

Auteurs

Lucie Richard (L)

MAP Centre for Urban Health Solutions, Unity Health Toronto, Toronto, Ontario, Canada.

Rosane Nisenbaum (R)

MAP Centre for Urban Health Solutions, Unity Health Toronto, Toronto, Ontario, Canada.

Michael Brown (M)

Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.

Michael Liu (M)

MAP Centre for Urban Health Solutions, Unity Health Toronto, Toronto, Ontario, Canada.
Harvard Medical School, Boston, Massachusetts.

Cheryl Pedersen (C)

MAP Centre for Urban Health Solutions, Unity Health Toronto, Toronto, Ontario, Canada.

Jesse I R Jenkinson (JIR)

MAP Centre for Urban Health Solutions, Unity Health Toronto, Toronto, Ontario, Canada.

Sharmistha Mishra (S)

MAP Centre for Urban Health Solutions, Unity Health Toronto, Toronto, Ontario, Canada.
Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada.
Division of Epidemiology and Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.

Stefan Baral (S)

Department of Epidemiology, John Hopkins University, Baltimore, Maryland.

Karen Colwill (K)

Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.

Anne-Claude Gingras (AC)

Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.

Allison McGeer (A)

Department of Microbiology, Mount Sinai Hospital, Toronto, Toronto, Ontario, Canada.

Stephen W Hwang (SW)

MAP Centre for Urban Health Solutions, Unity Health Toronto, Toronto, Ontario, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Department of General Internal Medicine, University of Toronto, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH